Tag: Lung Cancer
Tempus reads lung tumour slides to sort who needs which test
A Tempus panel squeezed above 80% sensitivity on all 12 lung cancer biomarkers using nothing but routine H&E slides.
Maverix secures 510(k) for its console-free Narwhal Pro lung cryoprobe
A 510(k) clearance has been won by Maverix Medical for the Narwhal Pro Cryo System, the second of two flexible…
MD Anderson’s CIPHER model flags lung toxicity risk before treatment
A model trained on pretreatment scans can flag lung toxicity risk before immunotherapy starts, holding an AUC of about 0.83…
An AI biotech of 37,000 agents flags a lung cancer target
A Stanford team built a virtual drug company staffed by 37,000 AI agents, and it has flagged a lung cancer…
Lung cancer AI outpredicts PD-L1 on who benefits from immunotherapy
A Nature Medicine study spanning six countries found AI models beat standard biomarkers at forecasting immunotherapy response in advanced lung…
Altis Labs banks $25M as its imaging endpoint beats RECIST
The Toronto company raised a Series A co-led by OrbiMed and Qiming Venture Partners USA for AI that reads trial…
Flatiron adds AI-extracted biomarkers to 345,000-patient lung dataset
Flatiron Health's lung cancer dataset gains AI-extracted biomarker detail across more than 345,000 patients.
J&J’s Monarch bronchoscopy robot adds AI planning in Quest 3
FDA clearance brings AI nodule planning and sharper navigation to J&J's Monarch lung biopsy robot.